This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don’t share our data with other parties. Read more about our cookie policy

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Read more about our cookie policy

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

About the NKI

The Netherlands Cancer Institute was established on October 10, 1913. The founders, Rotgans, professor of Surgery, De Bussy, publisher, and De Vries, professor of Pathology, wanted to create a cancer institute 'where patients suffering from malignant growths could be treated adequately and where cancer and related diseases could be studied'. They bought a house on one of the canals in Amsterdam and named it the 'Antoni van Leeuwenhoek Huis', after the famous Dutch microscopist. The clinic had room for 17 patients, while the laboratory could accommodate 8 to 10 scientists.

Nowadays, The Netherlands Cancer Institute accommodates approximately 650 scientists and scientific support personnel. The Antoni van Leeuwenhoek Hospital has 185 medical specialists, 180 beds, an out-patients clinic with around 106,000 visits, 12 operating theaters and 11 irradiotion units for radiotherapy. It is the only dedicated cancer center in The Netherlands and maintains an important role as a national and international center of scientific and clinical expertise, development and training.


  • 17Feb 2017

    Thijn Brummelkamp receives Vici grant of 1.5 million Euro

    Netherlands Cancer Institute (NKI) researcher Thijn Brummelkamp has received a Vici grant of 1.5 million Euro from the Netherlands Organization for Scientific Research (NWO). The Vici is one of the most important and largest Dutch grants for individual researchers.

    Read More
  • 10Feb 2017

    Over 17 million Euros in grants for research into precancerous breast cancer

    Women with a precancerous stage of breast cancer, DCIS [Ductal carcinoma in situ], are now all treated as if they have cancer. Pathologist Jelle Wesseling from the Netherlands Cancer Institute has received a multimillion Euro grant and award from Cancer Research UK and KWF [Dutch Cancer Society] (Grand Challenge) to change this.

    Read More
  • 09Feb 2017

    New approach to the development of cancer treatments can significantly reduce costs

    Cancer experts call for action to make cancer treatment medication affordable again. Universities should look for new partners in order to get their discoveries available to patients for reasonable prices.

    Read More
  • 08Feb 2017

    Thesis defense Anna Stiekema

    Anna Stiekema's PhD research focused on a potential new biomarker for different clinical applications of ovarian cancer and endometrial cancer. She will defend her thesis on Thursday, February 9.

    Read More

Board of Directors

Overview boards and commissions


Internal procedures

The NKI has adopted several regulations and procedures which help us organize our research along national and international standards. The most important regulations and procedures can be found here.

Read more


Technology Transfer Office

The NKI has a mission to beat cancer and performs world-beating research to increase our understanding of this disease. The knowledge that is gained in this way sometimes opens avenues for development of e.g. novel treatments or new diagnostic tests. To achieve its mission, NKI actively collaborates with private companies that have the knowledge and the means to develop products based on research results obtained at our institution.

Go to the site of the Technology Transfer Office

Scientific Annual Reports (SAR)



Group Leaders51
PhD Students187


  • Silhoutten



  • Silhoutten



  • Horloge



  • Silhoutten



  • Bed



Key Figures Research

Publications in 2014 542
Total impact of publications in 2014 3712
Avarage impact of publications 2014 6.8

Key Figures Research

Number of divisions 15
Number of Reseach groups 51
Share this page